Score2 CRVO (Penn State)

Study: Ongoing, but not recruiting participants

ClinicalTrials.gov Identifier: NCT01969708

Score2: Study of Comparative Treatments for Retinal Vein Occlusion 2 [Score 2]: a multi-center, prospective, randomized non-inferiority trial of eyes with macular edema secondary to central retinal vein occlusion, comparing intravitreal bevacizumab every 4 weeks with intravitreal aflibercept every 4 weeks.

Condition: Central Retinal Vein Occlusion

Study Type: Interventional

Duration: 12 months

Eligibility:

  • Ages: 18 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.